Table 5. p Values Associated with Comparison of ED50 Values between Vaccine Groups as Analyzed by Repeated Measures ANOVA.
| Vaccine Group | WTrPA10 | WTrPA2.5 | WTrPA0.625 | mrPA10 | mrPA2.5 | mrPA0.625 | AVA |
|---|---|---|---|---|---|---|---|
| wtrPA 10 μg | – | ||||||
| wtrPA 2.5 μg | < .0001↓ | – | |||||
| wtrPA 0.625 μg | < .0001↓ | NS | – | ||||
| mrPA 10 μg | .0003↑ | < .0001↑ | < .0001↑ | – | |||
| mrPA 2.5 μg | NS | < .0001↑ | < .0001↑ | NS | – | ||
| mrPA 0.625 μg | NS | < .0001↑ | < .0001↑ | < .0001↓ | NS | – | |
| AVA | NS | < .0001↑ | < .0001↑ | .0002↓ | NS | NS | – |
TNA ED50 values from blood draws between day -1 and 65 were analyzed by repeated measures ANOVA.
The ED50 response of non-vaccinated groups (None and Vehicle, not shown) were significantly lower (p < 0.0001) than every other group except each other.
↓Indicates the ED50 response of the vaccine group listed on the left is less than the corresponding vaccine group listed on the top of the table.
↑Indicates the ED50 response of the vaccine group listed on the left is greater than the corresponding vaccine group listed on the top of the table.
NS, no statistical significance between the reactions of the two groups.